The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Novartis AG (NVS)     Sector: Healthcare  >  Industry: Major Drugs
ETFI Global Healthcare Sector PerformIdex

Nov 14, 2008 12:02 AM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Global Health Composite Index Representing 400 Companies


The accompanying table presents the top five rated companies with market caps of at least $250 million (USD) from each of the nine new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 400 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 45 top rated companies ranging from small-caps to mega-caps from the following underlying healthcare indexes:

1.) ETFI Global Hospitals – Fresenius Medical (FMS)
2.) ETFI New Drug Regulatory Catalyst – Johnson & Johnson (JNJ)
3.) ETFI Global AnimalBiz – Alpharma (ALO)
4.) ETFI Health Benefit Providers – MedcoHealth Solutions (MHS)
5.) ETFI Cosmetic & Reconstructive Medicine – NuVasive (NUVA)
6.) ETFI Global Generic Drugs – Teva Pharma (TEVA)
7.) ETFI Global Health Information Technology – Masimo (MASI)
8.) ETFI Preventive Medicine – Myriad Genetics (MYGN)
9.) ETFI Global Health Innovators – Novartis (NVS)


Click on any of the links to view the most recent article on each of the underlying healthcare indexes and the companies listed are the largest by market cap included in the ETFI Global Healthcare Sector PerformIdex of 45 companies.


NVS:  This call was made on 11/14/08 @ $49.48
Rating:   Positive   $49.48 (11/14/08)
Closed:   03/06/2009 @ $35.41 (-28.44% in 111 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
Jpeg_sun4agk
Locationh   61%     1 point   commented 359 days ago reply

You may have missed getting in at the bottom (41) but great call.


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.23% 368
2 18.14 +70.19% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 60
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Novartis AG (NVS)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
80.5%
Top:
50.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
EXAS Positive +0.00% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.18% 11/04/09

View All >
   
Mike Havrilla previously rated NVS
Positive +20.19% BioMedReports FDA Calendar: Swine Flu Trial Set to Begin
07/21/2009
9
Positive +17.87% Updated FDA, Clinical Trial Calendars: AZN, MYGN, NVS, PSDV
04/08/2009
9
Positive -3.12% A Resurgence in Cell Therapeutics
04/02/2009
9
Positive +4.88% Updated Clinical Trial and FDA Decision Calendars
03/15/2009
9
Positive +3.59% Momenta Pharma's Three-Part Strategy
03/06/2009
9
Positive +1.46% Teva Beats on Profits: A Biogeneric Boon in '09?
11/06/2008
9
Positive +3.66% My 60 Defensive Growth Stock Picks at Inner8.com
10/25/2008
9
Positive -4.37% Expanding Defensive Growth Index into Europe
10/23/2008
9
Positive -10.66% A Waiting Game for Momenta Pharma
09/26/2008
3
Positive -6.69% Novartis: An ex-US Proxy for Global Healthcare
07/26/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch